Iain’s scientific background lies in cell biology, and a continued interest in this field led him to develop a patent practice with a significant leaning towards cell-based therapies. Areas of particular focus include technologies relating to the production and development of immunotherapies (such as CAR-T cells), and the medical uses of stem cells (whether for regenerative medicine or the production of therapeutic cell types). He acts for clients ranging from universities to large pharma companies, and has nearly two decades of experience drafting and co-ordinating the prosecution of biotech patent portfolios.